The role of complementary and alternative medicine in therapy of multiple sclerosis

Acta Clinica Croatica

Volumn 52, Issue 4, 2015, Pages 464-471

  Kes, Vanja Bašić ^a   Cesarik, Marijan ^b   Matovina, Lucija Zadro ^a   Zavoreo, Iris ^a   Ćorić, Lejla ^a   Drnasin, Sara ^a   Demarin, Vida ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Department of Surgery   (Croatia)

Author keywords

Antioxidants; Complementary therapies; Diet, fat restricted; Dietary supplements; Fatty acids, essential; Multiple sclerosis therapy

Indexed keywords

ANTIOXIDANT; CANNABIS; CYANOCOBALAMIN; DRUG THERAPY; NALTREXONE; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; THIOCTIC ACID; VITAMIN; VITAMIN D;

ACUPUNCTURE; ALLOPATHY; ALTERNATIVE MEDICINE; APITHERAPY; ARTICLE; CHINESE MEDICINE; CRANBERRY; DIET SUPPLEMENTATION; ECHINACEA; EPIDEMIOLOGY; GINKGO BILOBA; GINSENG; HEALTH BEHAVIOR; HERBAL MEDICINE; HUMAN; HYPERBARIC OXYGEN; HYPERICUM PERFORATUM; LOW FAT DIET; METHODOLOGY; MULTIPLE SCLEROSIS; NATIONAL HEALTH ORGANIZATION; PERSONALIZED MEDICINE; REVIEW; SELF CARE; STATISTICS; TAI CHI; THERAPY; UTILIZATION REVIEW; VITAMIN SUPPLEMENTATION; YOGA;

ANTIOXIDANTS; COMPLEMENTARY THERAPIES; DIET, FAT-RESTRICTED; EPIDEMIOLOGY; FATTY ACIDS, OMEGA-3; HEALTH BEHAVIOR; HUMANS; INDIVIDUALIZED MEDICINE; METHODS; MULTIPLE SCLEROSIS; SELF CARE; STATISTICS AND NUMERICAL DATA; THERAPEUTIC USE; THERAPY; UTILIZATION; VITAMIN D; VITAMINS;

EID: 84995308990     PISSN: 03539466     EISSN: 13339451     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. What is Complementary and Alternative Medicine? National Center for Complementary and Alternative Medicine, 2010. Accessed August 5, 2010 at http://nccm.nihgov/health/whatiscam/
2. Complementary and Alternative Medicine in the United States. National Academy Press. ISBN 978-0-309-09270-8. Institute of Med (2005). http://www.nap.edu/catalog. php?record_id=11182.
3. YADAV V, SHINTO L, BOURDETTE D. Complementary and alternative medicine for the treatment for multiple sclerosis. Expert Rev Clin Immunol 2010; 6(3): 381-95.
4. Complementary and Alternative Medicine in the United States. David Nemer. ImproveHealthCare.org. November 2010. Accessed at: http:improvehealthcareorg.
5. BOWLING AC. Complementary and alternative medicine in multiple sclerosis. Continuum Lifelong Learning Neurol 2010; 16(5): 78-86.
6. BOWLING AC. Unconventional medicine and multiple sclerosis: the role of conventional health providers. In: Lucchineti CF, Hohlfeld R, editors. Multiple sclerosis 3 (Blue Books of Neurology series). Philadelphia, PA:Saunders, 2010;355-70.
7. NIH Consensus Development Panel on Acupuncture. JAMA 1998;280(17):1518-24.
8. BOWLING AC, STEWART TM. Dietary supplements and multiple sclerosis: a health professional's guide. New York, NY: Demos Medical Publishing, 2004.
9. BOWLING AC. Complementary and alternative medicine and multiple sclerosis. New York, NY: Demos Medical Publishing, 2007.
10. WESSELIUS T, HEERSEMA DJ, MOSTERT JP et al. A randomized crossover study of bee sting therapy for multiple sclerosis. Neurology 2005; 65(11): 1764-8.
11. SONG HS, WRAY SH. Bee sting optic neuritis: a case report with visual evoked potentials. J Clin Neuroophthalmol 1991; 11(1): 1145-9.
12. CASTRO HJ, MENDEZ-LNOCENCIO JI, OMIDVAR B et al. A phase I study of the safety of honeybee venom extract as a possible treatment for patients with progressive form of multiple sclerosis. Allergy Asthma Proc 2008; 26(6): 470-6.
13. MARACCI GH, JONES RE, McKEON GP, BORDETTE DN. Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol 2002;131(1-2):104-14.
14. SCOTT GS, SPITSIN SV, KEAN RB et al. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci USA 2002; 99(25): 16303-8.
15. SPITSIN S, HOOPER DC, LEIST T et al. Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease. Mult Scler 2001; 7(5): 313-9.
16. YADAV V, MARACCI G, LOVERA J et al. Lipoic acid in multiple sclerosis: a pilot study. Mult Scler 2005; 11(2): 159-65.
17. MAI J, SORENSON P, HANSEN J. High dose antioxidant supplementation to MS patients: effects on glutathione peroxidase, clinical safety, and absorption of selenium. Biol Trace Elem Res 1990; 24(2): 109-17.
18. HESS MJ, HESS PE, SULLIVAN MR et al. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008; 46(9): 622-6.
19. BOWLING AC, STEWART TM. Current complementary and alternative therapies of multiple sclerosis. Curr Treat Options Neurol 2003; 5(1): 55-68.
20. BLUMENTHAL M. Asian ginseng: potential therapeutic uses. Adv Nurse Pract 2001; 9: 26-8.
21. LEE J, ZHAO Y, LIAND X-J. Current evaluation of the millennium phytomedicine-Ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine. Curr Med Chem 2009; 16: 2924-42.
22. LOVERA J, BAGERT B, SMOOT K et al. Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized placebo-controlled trial. Mult Scler 2007; 13(3): 376-85.
23. JOHNSON SK, DIAMOND BJ, RAUSCH S et al. The effect of ginkgo biloba on functional measure in multiple sclerosis: a pilot randomized controlled trial. Explore (NY) 2006; 2(1): 19-24.
24. BROCHET B, GUINOT P, ORGOGOZO J et al. Double blind, placebo controlled, multicentre study of ginkolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkolide Study Group in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995; 58(3): 360-2.
25. JELLIN JM, GREGORY PJ, BATZ F et al. Natural medicines comprehensive database (pharmacist's letter/prescriber's letter). 8th edn. Stockton, CA: Therapeutic Research Faculty, 2006;2010.
26. WERNEKE U, HORN O, TAYLOR DM. How effective is St John's wort?: the evidence revisited. J Clin Psychiatry 2004; 65(5): 611-7.
27. WADE DT, YOUNG CA, CHAUDHURI KR, DAVIDSON DL. A randomized placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Carl Loder regime") in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 73(3): 246-9.
28. WEINSTOCK-GUTTMAN B, GALLAGHER E, BAIER M et al. Risk of bone loss in men with multiple sclerosis. Mult Scler 2004; 10(2): 170-5.
29. SMOLDERS J, DAMOISEAUX J, MENHEERE P. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008;194(1-2):7-17.
30. MUNGER KL, LEVIN LI, HOLLIS BW et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296(23): 2832-8.
31. SWANK R, DUGAN B. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 1990; 336(8706): 37-9.
32. STEWART TM, BOWLING AC. Polyunsaturated fatty acid supplementation in MS. Int MS J 2005; 12(3): 88-93.
33. BATES D, CARTLIDGE N, FRENCH J et al. A doubleblind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neuorsurg Psychiatry 1989; 52(1): 18-22.
34. WEINSTOCK-GUTTMAN B, BAIER M, PARK Y et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids 2005; 3(5): 392-404.
35. BENNETT M, HEARD R. Hyperbaric oxygen therapy for multiple sclerosis. CNS Neurosci Ther 2010; 16(2): 115-24.
36. CREE BAC, KRONYEYEVA E, GOODIN DS. Pilot trial of low dose naltrexone and quality of life in MS. Ann Neurol 2010;9999(999A).
37. GIRONI M, MARTINELLI-BONESCHI F, SACERDOTE P et al. A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis. Mult Scler 2008; 14(8): 1076-83.
38. ZAJICEK JP, SANDERS HP, WRIGHT DE et al. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 month follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1664-9.
39. BARNES MP. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother 2006; 7(5): 607-15.
40. BAŠIĆ-KES V, BOŠNJAK-PAŠIĆ M, DEMARIN V. Pain syndromes in patients with multiple sclerosis. Acta Clin Croat 2007; 46: 331-3.
41. HUSTED C, PHAM L, HEKKING A, NIEDERMAN R. Improving quality of life for people with chronic conditions:the example of t'ai chi and multiple sclerosis. Altern Ther Health Med 1999; 5(5): 70-4.
42. OKEN BS, KISHIYAMAS, ZAJDEL D et al. Randomized controlled trial of yoga and exercise in multiple sclerosis. Neurology 2004; 62(11): 2058-64.